{"schema_version":"secwatch.filing_event.v1","accession":"0001792044-24-000014","form_type":"8-K","ticker":"VTRS","cik":"0001792044","company_name":"Viatris Inc","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.134886+00:00","generated_at":"2026-06-02T06:40:55.766475+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Viatris reports strong Q1: revenue $3.66B, adj. EPS $0.67, free cash flow $565M","bullets":["Q1 revenue $3.66B, GAAP net earnings $113.9M; adjusted EBITDA $1.19B; GAAP EPS $0.09, adjusted EPS $0.67.","Fourth consecutive quarter of operational revenue growth on a divestiture-adjusted basis; total sales declined 2% GAAP but grew 2% adjusted.","Closed Idorsia collaboration and Women's Healthcare divestiture; expects API divestiture imminent.","Returned $393M to shareholders in Q1 via dividends and share repurchases; declared quarterly dividend of $0.12 per share.","Reaffirmed 2024 guidance: new product revenue $450-550M; free cash flow target reaffirmed."],"urls":{"canonical":"https://secwatch.observer/filing/0001792044-24-000014","json":"https://secwatch.observer/filing/0001792044-24-000014.json","markdown":"https://secwatch.observer/filing/0001792044-24-000014.md","text":"https://secwatch.observer/filing/0001792044-24-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1792044/000179204424000014/0001792044-24-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1792044/000179204424000014/vtrs-20240509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T06:40:55.766475+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1105ea22c3951360320eb95afde910bc3f17d119","claim":"Viatris Inc reported the first quarter of 2024 results: revenue $3.66 Billion, net income $113.9 Million, EPS $0.09. Guidance reaffirmed.","evidence_excerpt":"Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges • Reports Total Revenues of $3.66 Billion; U.S. GAAP Net Earnings of $113.9 Million; Adjusted EBITDA of $1.19 Billion; U.S. GAAP EPS of $0.09; Adjusted EPS of $0.67","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1792044/000179204424000014/0001792044-24-000014-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter of 2024"},{"label":"Revenue","value":"$3.66 Billion"},{"label":"Net income","value":"$113.9 Million"},{"label":"EPS","value":"$0.09"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}